Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

Novel antiinflammatory protein available for licensing

Jan. 22, 1997

AutoImmune updates clinical program for oral RA product

Jan. 17, 1997

Genelabs completes first pivotal trial on SLE Rx

Jan. 16, 1997

Chiroscience investigates MMP/TNF inhibitors

Jan. 16, 1997

Searle describes antiinflammatory oxazoles

Jan. 15, 1997

New COX-2 inhibitor series reported by Merck Frosst

Jan. 15, 1997

Chiroscience reports new peptidyl compounds for treating degenerative diseases

Jan. 14, 1997

Phase I ConXn data reported

Jan. 10, 1997

Chondrex license agreement option exercised

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...